NANOVIRICIDES, INC. — Director's Dealing 2013

Mar 5, 2013

SEC Form 4/A — Form 4/A

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2013-03-04

Reporting Person: Diwan Anil (Director, President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-04	Common Stock	P	147000	$0.5	Acquired	6379200	Direct

Footnotes

F1: Does not include 1,000,000 shares of NanoViricides common stock issuable upon exercise of options held by Dr. Diwan that are currently exercisable or will become exercisable within 60 days or 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.